Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04119037Active, not recruiting
Randomised, double-blind trial in cancer pain (2 arms), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Reduction in pain intensity at 6 months. Started Sep 2019; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04119037.